IP Library Granted Patent US 11,224,516
Granted Patent B2
US 11,224,516 · App. 15/049,155 · Granted Jan 18, 2022

Hip joint device and method

Inventor: Peter Forsell (Bouveret, CH)
A61F2/36A61F2/30721A61L27/20A61L27/26A61L27/50A61F2/68A61F2/70A61F2002/30566A61F2002/30601A61F2002/30668A61F2002/30673A61F2002/30675A61F2002/7635A61L2400/10B25J9/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,224,516
App. No.
15/049,155
Granted
Jan 18, 2022
Kind
B2
Abstract

An implantable medical device for lubrication of a synovial joint having a joint cavity is provided. The implantable device comprises a solid lubricant and a feeding device, wherein said feeding device is adapted to feed said solid lubricant into the joint cavity for lubricating the synovial joint.

Claims (37)

1. An implantable medical device for lubrication of a patient's synovial joint having a joint cavity, specifically a hip joint or a knee joint, wherein said implantable device comprises a solid lubricant and an implantable feeding device, wherein said feeding device comprises a force exerting member for creating a relative movement between the solid lubricant and the feeding device, wherein said force exerting member is adapted to push said solid lubricant into the joint cavity for lubricating the synovial joint non-invasively while being entirely implanted, wherein said implantable medical device comprises a replaceable implantable cartridge containing said solid lubricant, wherein said medical device further comprises a control device for controlling said force exerting member in response to a pre-programmed time-schedule or in response to a sensor sensing a physical parameter of the patient.

2. The implantable medical device according to claim 1 , wherein said replaceable implantable cartridge having an opening into the joint cavity, when implanted, wherein an inner diameter of said opening has substantially the same diameter as the inner diameter of said cartridge.

3. The implantable medical device according to claim 1 , wherein said solid lubricant has thixotropic or shear thinning properties, such that the viscosity of said solid lubricant is reduced when said solid lubricant is exposed to strain in the joint cavity.

4. The implantable medical device according to claim 1 , wherein said solid lubricant comprises high-molecular weight hyaluronic acid.

5. The implantable medical device according to claim 1 , wherein said solid lubricant comprises crosslinked high-molecular weight hyaluronic acid.

6. The implantable medical device according to claim 1 , wherein said solid lubricant comprises hyaluronic acid of at least two different high-molecular weights, crosslinked to form a semisolid or solid gel.

7. The implantable medical device according to claim 1 , wherein said solid lubricant comprises a crosslinking agent chosen from 1, 2, 3, 4-diepoxybutane, divinyl sulfone.

8. The implantable medical device according to claim 1 , wherein said solid lubricant comprises a hydrophilic polymer chosen from synthetic and natural polysaccharides.

9. The implantable medical device according to claim 8 , wherein said hydrophilic polymer comprises a hydrophilic polymer selected from a group consisting of:

a. hydroxyethyl cellulose,

b. carboxymethyl cellulose,

c. xanthan gum,

d. chondroitin sulfate,

e. heparin,

f. protein,

g. sulfated protein,

h. synthetic water-soluble polymers.

10. The implantable medical device according to claim 9 , wherein said protein comprises a protein selected from a group consisting of:

a. collagen,

b. elastin,

c. albumin, and

a globulin.

11. The implantable medical device according to claim 9 , wherein said sulfated protein comprises a sulfated protein selected from a group consisting of:

a. keratin sulfate, and

b. sulfated aminoglycosaminoglycans.

12. The implantable medical device according to claim 9 , wherein said synthetic water-soluble polymer is a synthetic water-soluble polymer selected from a group consisting of:

a. polyvinyl alcohol,

b. co-polymers of polyvinyl alcohol, and

c. co-polymers of poly-(hydroxethyl) methacrylate.

13. The implantable medical device according to claim 1 , wherein said medical device is adapted to be implanted in the area of the hip joint, such that said solid lubricant can be inserted into the joint cavity of the hip joint.

14. The implantable medical device according to claim 13 , wherein said medical device is adapted to at least partially be implanted in the caput femur, such that the feeding device can feed the solid lubricant into the hip joint cavity, towards the acetabulum.

15. The implantable medical device according to claim 13 , wherein the implantable device is adapted to be inserted into a bore in the femoral bone.

16. The implantable medical device according to claim 15 , wherein the medical device is adapted to be inserted into the bore from the lateral side of the femoral bone, preferable in the region distally of the trochanter major.

17. The implantable medical device according to claim 13 , wherein said medical device is adapted to at least partially be implanted in the pelvis, such that the feeding device can feed the solid lubricant into the hip joint cavity, towards the caput femur.

18. The implantable medical device according to claim 13 , wherein the implantable device is adapted to be inserted into a bore in the pelvis.

19. The implantable medical device according to claim 18 , wherein the medical device is adapted to be inserted into the bore in the pelvis, from the acetabulum side of the pelvic bone.

20. The implantable medical device according to claim 18 , wherein the medical device is adapted to be inserted into the bore in the pelvis, from the abdominal side of the pelvic bone.

Priority Claims (17)
SE 0900957-2 · Jul 10, 2009 · national
SE 0900958-0 · Jul 10, 2009 · national
SE 0900959-8 · Jul 10, 2009 · national
SE 0900960-6 · Jul 10, 2009 · national
SE 0900962-2 · Jul 10, 2009 · national
SE 0900963-0 · Jul 10, 2009 · national
SE 0900965-5 · Jul 10, 2009 · national
SE 0900966-3 · Jul 10, 2009 · national
SE 0900968-9 · Jul 10, 2009 · national
SE 0900969-7 · Jul 10, 2009 · national
SE 0900970-5 · Jul 10, 2009 · national
SE 0900972-1 · Jul 10, 2009 · national
SE 0900973-9 · Jul 10, 2009 · national
SE 0900974-7 · Jul 10, 2009 · national
SE 0900976-2 · Jul 10, 2009 · national
SE 0900978-8 · Jul 10, 2009 · national
SE 0900981-2 · Jul 10, 2009 · national
Continuity (19)
Continuation 13382853
Provisional Application 61229739 · Jul 30, 2009
Provisional Application 61229743 · Jul 30, 2009
Provisional Application 61229746 · Jul 30, 2009
Provisional Application 61229747 · Jul 30, 2009
Provisional Application 61229748 · Jul 30, 2009
Provisional Application 61229751 · Jul 30, 2009
Provisional Application 61229752 · Jul 30, 2009
Provisional Application 61229755 · Jul 30, 2009
Provisional Application 61229761 · Jul 30, 2009
Provisional Application 61229767 · Jul 30, 2009
Provisional Application 61229778 · Jul 30, 2009
Provisional Application 61229796 · Jul 30, 2009
Provisional Application 61229735 · Jul 30, 2009
Provisional Application 61229738 · Jul 30, 2009
Provisional Application 61229745 · Jul 30, 2009
Provisional Application 61229789 · Jul 30, 2009
Provisional Application 61229786 · Jul 30, 2009
Related Publication 20170021153A1 · Jan 26, 2017
Cited By (1)
US 12,226,316